Mark Nehler
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 32 | 2024 | 458 | 4.350 |
Why?
| Ischemia | 30 | 2024 | 396 | 4.200 |
Why?
| Internship and Residency | 17 | 2024 | 1056 | 2.450 |
Why?
| Lower Extremity | 21 | 2024 | 404 | 2.450 |
Why?
| Vascular Surgical Procedures | 25 | 2024 | 295 | 2.230 |
Why?
| General Surgery | 10 | 2024 | 156 | 2.050 |
Why?
| Rivaroxaban | 19 | 2024 | 255 | 1.980 |
Why?
| Endovascular Procedures | 11 | 2024 | 308 | 1.640 |
Why?
| Leg | 14 | 2007 | 241 | 1.500 |
Why?
| Platelet Aggregation Inhibitors | 17 | 2024 | 453 | 1.470 |
Why?
| Peripheral Vascular Diseases | 12 | 2022 | 105 | 1.360 |
Why?
| Aspirin | 16 | 2024 | 379 | 1.280 |
Why?
| Blood Vessel Prosthesis Implantation | 6 | 2023 | 202 | 1.030 |
Why?
| Factor Xa Inhibitors | 9 | 2024 | 171 | 1.030 |
Why?
| Limb Salvage | 10 | 2024 | 59 | 1.030 |
Why?
| Surgeons | 4 | 2021 | 279 | 0.890 |
Why?
| Femoral Artery | 10 | 2023 | 176 | 0.840 |
Why?
| Education, Medical, Graduate | 6 | 2024 | 438 | 0.820 |
Why?
| Arterial Occlusive Diseases | 7 | 2008 | 79 | 0.820 |
Why?
| Treatment Outcome | 46 | 2024 | 10299 | 0.780 |
Why?
| Aortic Aneurysm, Abdominal | 3 | 2017 | 138 | 0.710 |
Why?
| Risk Factors | 36 | 2025 | 9832 | 0.710 |
Why?
| Career Choice | 4 | 2024 | 211 | 0.700 |
Why?
| Popliteal Artery | 7 | 2023 | 60 | 0.690 |
Why?
| Puerperal Disorders | 1 | 2020 | 30 | 0.680 |
Why?
| Intermittent Claudication | 12 | 2022 | 118 | 0.680 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 79 | 0.660 |
Why?
| Venous Thromboembolism | 4 | 2025 | 273 | 0.650 |
Why?
| Personnel Selection | 3 | 2018 | 73 | 0.640 |
Why?
| Thrombosis | 5 | 2024 | 331 | 0.640 |
Why?
| Postoperative Complications | 12 | 2024 | 2500 | 0.630 |
Why?
| Vascular System Injuries | 4 | 2021 | 73 | 0.610 |
Why?
| Aged | 50 | 2025 | 22113 | 0.600 |
Why?
| Vascular Patency | 13 | 2023 | 102 | 0.600 |
Why?
| Humans | 116 | 2025 | 129705 | 0.580 |
Why?
| Time Factors | 21 | 2022 | 6593 | 0.570 |
Why?
| Male | 74 | 2025 | 63544 | 0.560 |
Why?
| Risk Assessment | 16 | 2025 | 3297 | 0.560 |
Why?
| Coronary Artery Disease | 5 | 2024 | 695 | 0.540 |
Why?
| Female | 69 | 2025 | 68561 | 0.530 |
Why?
| Quality Indicators, Health Care | 3 | 2016 | 299 | 0.510 |
Why?
| Clinical Competence | 4 | 2022 | 1026 | 0.510 |
Why?
| Elective Surgical Procedures | 2 | 2017 | 164 | 0.510 |
Why?
| Middle Aged | 51 | 2025 | 31103 | 0.500 |
Why?
| Mentors | 2 | 2020 | 174 | 0.490 |
Why?
| Arteriovenous Shunt, Surgical | 2 | 2011 | 16 | 0.450 |
Why?
| Angioplasty, Balloon | 3 | 2023 | 90 | 0.420 |
Why?
| Renal Dialysis | 3 | 2013 | 417 | 0.420 |
Why?
| Upper Extremity | 2 | 2011 | 95 | 0.410 |
Why?
| Aged, 80 and over | 22 | 2024 | 7074 | 0.410 |
Why?
| Retrospective Studies | 27 | 2024 | 14669 | 0.410 |
Why?
| Incidence | 10 | 2025 | 2658 | 0.400 |
Why?
| Paclitaxel | 3 | 2021 | 214 | 0.400 |
Why?
| Kidney Failure, Chronic | 4 | 2013 | 548 | 0.360 |
Why?
| Patient Care Management | 1 | 2011 | 57 | 0.360 |
Why?
| Drug Therapy, Combination | 9 | 2024 | 1024 | 0.350 |
Why?
| Alprostadil | 2 | 2007 | 32 | 0.340 |
Why?
| Activities of Daily Living | 4 | 2006 | 383 | 0.340 |
Why?
| Medicaid | 1 | 2014 | 447 | 0.330 |
Why?
| Quality of Life | 6 | 2022 | 2712 | 0.330 |
Why?
| Patient Readmission | 5 | 2023 | 675 | 0.320 |
Why?
| Wound Healing | 5 | 2009 | 310 | 0.320 |
Why?
| Adult | 33 | 2025 | 35595 | 0.310 |
Why?
| Continuity of Patient Care | 1 | 2011 | 279 | 0.310 |
Why?
| Medicare | 1 | 2014 | 734 | 0.300 |
Why?
| Brain Ischemia | 2 | 2022 | 308 | 0.300 |
Why?
| Drug-Eluting Stents | 2 | 2021 | 65 | 0.300 |
Why?
| Kidney Diseases | 2 | 2011 | 367 | 0.300 |
Why?
| United States | 17 | 2025 | 14078 | 0.290 |
Why?
| Comorbidity | 7 | 2017 | 1545 | 0.290 |
Why?
| Students, Medical | 2 | 2023 | 307 | 0.280 |
Why?
| Decision Support Techniques | 2 | 2021 | 388 | 0.280 |
Why?
| Ribs | 2 | 2016 | 33 | 0.270 |
Why?
| Critical Illness | 6 | 2020 | 765 | 0.270 |
Why?
| Stroke | 3 | 2022 | 1111 | 0.270 |
Why?
| Curriculum | 5 | 2024 | 933 | 0.270 |
Why?
| Prodrugs | 1 | 2007 | 49 | 0.270 |
Why?
| Computer Simulation | 1 | 2011 | 947 | 0.270 |
Why?
| Surveys and Questionnaires | 10 | 2024 | 5396 | 0.270 |
Why?
| Neoplasms | 1 | 2021 | 2435 | 0.260 |
Why?
| Anticoagulants | 5 | 2025 | 623 | 0.260 |
Why?
| Software | 1 | 2011 | 611 | 0.260 |
Why?
| Myocardial Infarction | 3 | 2022 | 1032 | 0.260 |
Why?
| Venous Thrombosis | 2 | 2025 | 165 | 0.260 |
Why?
| Thoracic Outlet Syndrome | 2 | 2016 | 15 | 0.250 |
Why?
| Atherosclerosis | 2 | 2020 | 392 | 0.250 |
Why?
| Attitude of Health Personnel | 3 | 2024 | 1092 | 0.250 |
Why?
| Catheterization, Peripheral | 2 | 2009 | 104 | 0.240 |
Why?
| Hemorrhage | 7 | 2023 | 697 | 0.240 |
Why?
| Femoral Vein | 3 | 2008 | 31 | 0.240 |
Why?
| Reoperation | 10 | 2014 | 555 | 0.240 |
Why?
| Graft Occlusion, Vascular | 3 | 2011 | 39 | 0.240 |
Why?
| Cardiovascular Surgical Procedures | 2 | 2001 | 30 | 0.240 |
Why?
| Iliac Aneurysm | 2 | 2022 | 21 | 0.230 |
Why?
| Carotid Stenosis | 2 | 1996 | 86 | 0.230 |
Why?
| Parental Leave | 1 | 2024 | 25 | 0.220 |
Why?
| Patient Care Team | 2 | 2024 | 607 | 0.220 |
Why?
| Urology | 1 | 2024 | 58 | 0.220 |
Why?
| Ultrasonography, Doppler | 2 | 2021 | 118 | 0.220 |
Why?
| Fibrinolytic Agents | 3 | 2022 | 264 | 0.220 |
Why?
| Chi-Square Distribution | 3 | 2017 | 517 | 0.220 |
Why?
| Acute Disease | 4 | 2021 | 984 | 0.210 |
Why?
| Cranial Nerve Injuries | 1 | 2023 | 5 | 0.210 |
Why?
| Carotid Body Tumor | 1 | 2023 | 5 | 0.210 |
Why?
| Diabetes Complications | 3 | 2015 | 227 | 0.210 |
Why?
| Double-Blind Method | 8 | 2024 | 1871 | 0.210 |
Why?
| Academic Medical Centers | 3 | 2017 | 474 | 0.210 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 83 | 0.210 |
Why?
| Diabetic Foot | 2 | 2019 | 23 | 0.200 |
Why?
| Antifibrinolytic Agents | 1 | 2023 | 54 | 0.200 |
Why?
| Pulmonary Embolism | 1 | 2025 | 214 | 0.200 |
Why?
| Tibial Arteries | 4 | 2008 | 12 | 0.200 |
Why?
| Cholesterol, LDL | 1 | 2024 | 360 | 0.200 |
Why?
| Meditation | 1 | 2022 | 39 | 0.200 |
Why?
| Thrombolytic Therapy | 1 | 2003 | 137 | 0.190 |
Why?
| Blood Coagulation Disorders | 1 | 2023 | 167 | 0.180 |
Why?
| Blood Vessel Prosthesis | 3 | 2022 | 126 | 0.180 |
Why?
| Faculty, Medical | 1 | 2024 | 263 | 0.180 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2023 | 128 | 0.180 |
Why?
| Smoking Cessation | 2 | 2002 | 411 | 0.180 |
Why?
| Heparin | 3 | 2023 | 252 | 0.180 |
Why?
| Quality Improvement | 2 | 2022 | 1113 | 0.180 |
Why?
| Hemostatic Techniques | 1 | 2001 | 46 | 0.180 |
Why?
| Outpatients | 1 | 2024 | 366 | 0.180 |
Why?
| Hospital Departments | 1 | 2020 | 9 | 0.170 |
Why?
| Aortic Diseases | 1 | 2001 | 112 | 0.170 |
Why?
| Specialties, Surgical | 2 | 2017 | 78 | 0.170 |
Why?
| Suture Techniques | 1 | 2001 | 121 | 0.170 |
Why?
| Mentoring | 1 | 2022 | 120 | 0.170 |
Why?
| Hyperlipidemias | 1 | 2001 | 124 | 0.170 |
Why?
| Blood Pressure Determination | 1 | 2021 | 150 | 0.170 |
Why?
| Forefoot, Human | 1 | 1999 | 6 | 0.170 |
Why?
| Multivariate Analysis | 4 | 2019 | 1507 | 0.170 |
Why?
| Toes | 1 | 1999 | 27 | 0.160 |
Why?
| Logistic Models | 3 | 2017 | 1980 | 0.160 |
Why?
| Aneurysm | 2 | 1997 | 31 | 0.160 |
Why?
| Proportional Hazards Models | 3 | 2021 | 1227 | 0.160 |
Why?
| Canagliflozin | 1 | 2019 | 9 | 0.160 |
Why?
| Self Concept | 1 | 2021 | 237 | 0.160 |
Why?
| Clinical Clerkship | 1 | 2020 | 89 | 0.160 |
Why?
| Databases, Factual | 4 | 2017 | 1297 | 0.160 |
Why?
| Patient Selection | 4 | 2014 | 685 | 0.160 |
Why?
| Counseling | 1 | 2002 | 384 | 0.160 |
Why?
| Walking | 4 | 2022 | 498 | 0.160 |
Why?
| Chronic Disease | 6 | 2011 | 1721 | 0.150 |
Why?
| Carotid Artery Diseases | 1 | 2019 | 64 | 0.150 |
Why?
| Drug Prescriptions | 1 | 2020 | 254 | 0.150 |
Why?
| Iatrogenic Disease | 1 | 1998 | 57 | 0.150 |
Why?
| School Admission Criteria | 1 | 2018 | 23 | 0.150 |
Why?
| Exercise Therapy | 2 | 2001 | 406 | 0.150 |
Why?
| Extremities | 2 | 2009 | 130 | 0.150 |
Why?
| Cardiovascular Diseases | 5 | 2024 | 2022 | 0.150 |
Why?
| Blood Vessels | 2 | 1998 | 184 | 0.150 |
Why?
| Odds Ratio | 3 | 2016 | 1025 | 0.140 |
Why?
| Arm | 2 | 2004 | 107 | 0.140 |
Why?
| Follow-Up Studies | 9 | 2021 | 4939 | 0.140 |
Why?
| Arteriosclerosis | 1 | 1997 | 86 | 0.140 |
Why?
| Physician Executives | 1 | 2017 | 33 | 0.140 |
Why?
| Ultrasonography, Doppler, Duplex | 2 | 1996 | 43 | 0.140 |
Why?
| Hospitalization | 2 | 2025 | 2091 | 0.140 |
Why?
| Cost of Illness | 1 | 2019 | 296 | 0.140 |
Why?
| Diabetes Mellitus | 3 | 2021 | 997 | 0.140 |
Why?
| Subclavian Artery | 1 | 1997 | 29 | 0.140 |
Why?
| Homocysteine | 1 | 1997 | 150 | 0.140 |
Why?
| Vascular Diseases | 2 | 2015 | 242 | 0.140 |
Why?
| Tertiary Care Centers | 1 | 2017 | 147 | 0.130 |
Why?
| Burnout, Professional | 1 | 2022 | 399 | 0.130 |
Why?
| Incidental Findings | 1 | 2016 | 80 | 0.130 |
Why?
| Endarterectomy, Carotid | 2 | 2013 | 47 | 0.130 |
Why?
| Vascular Malformations | 1 | 2016 | 51 | 0.130 |
Why?
| Sepsis | 2 | 2016 | 566 | 0.130 |
Why?
| Survival Rate | 4 | 2021 | 1894 | 0.120 |
Why?
| Osteotomy | 1 | 2016 | 164 | 0.120 |
Why?
| Interprofessional Relations | 1 | 2017 | 274 | 0.120 |
Why?
| Popliteal Vein | 1 | 1994 | 4 | 0.120 |
Why?
| Kaplan-Meier Estimate | 4 | 2021 | 863 | 0.120 |
Why?
| Hypertension | 2 | 2001 | 1240 | 0.110 |
Why?
| Multidetector Computed Tomography | 1 | 2014 | 33 | 0.110 |
Why?
| Disease Progression | 3 | 2014 | 2612 | 0.110 |
Why?
| Endarterectomy | 1 | 1993 | 6 | 0.110 |
Why?
| Multiple Trauma | 1 | 2014 | 103 | 0.110 |
Why?
| Thoracotomy | 1 | 2014 | 78 | 0.110 |
Why?
| Premedication | 1 | 1993 | 40 | 0.110 |
Why?
| Bandages | 1 | 1993 | 38 | 0.110 |
Why?
| Surgery, Computer-Assisted | 1 | 2014 | 76 | 0.110 |
Why?
| Recurrence | 4 | 2014 | 1016 | 0.110 |
Why?
| Recovery of Function | 3 | 2011 | 643 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 880 | 0.100 |
Why?
| Ulnar Artery | 1 | 1992 | 2 | 0.100 |
Why?
| Ischemic Attack, Transient | 1 | 1993 | 65 | 0.100 |
Why?
| Analgesics, Opioid | 1 | 2020 | 917 | 0.100 |
Why?
| Research Design | 2 | 2009 | 1048 | 0.100 |
Why?
| Injury Severity Score | 3 | 2021 | 554 | 0.100 |
Why?
| Life Tables | 3 | 1998 | 18 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 1291 | 0.100 |
Why?
| Stress, Psychological | 1 | 2020 | 1051 | 0.100 |
Why?
| Radial Artery | 1 | 1992 | 68 | 0.100 |
Why?
| Renal Insufficiency | 1 | 2014 | 150 | 0.100 |
Why?
| Fingers | 1 | 1992 | 87 | 0.100 |
Why?
| Predictive Value of Tests | 4 | 2021 | 1981 | 0.100 |
Why?
| Seasons | 1 | 2014 | 508 | 0.100 |
Why?
| Research Personnel | 1 | 2013 | 163 | 0.100 |
Why?
| Angiography | 2 | 2024 | 201 | 0.100 |
Why?
| Pregnancy | 2 | 2024 | 6273 | 0.090 |
Why?
| Thrombectomy | 2 | 2003 | 58 | 0.090 |
Why?
| Aorta, Thoracic | 1 | 2014 | 260 | 0.090 |
Why?
| Prognosis | 5 | 2021 | 3801 | 0.090 |
Why?
| Oregon | 1 | 2011 | 68 | 0.090 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2024 | 1379 | 0.090 |
Why?
| Young Adult | 6 | 2021 | 12363 | 0.090 |
Why?
| Efficiency | 1 | 2011 | 96 | 0.090 |
Why?
| Fellowships and Scholarships | 1 | 2013 | 271 | 0.090 |
Why?
| Hypoglycemic Agents | 1 | 2019 | 1206 | 0.090 |
Why?
| Arteries | 2 | 2022 | 268 | 0.080 |
Why?
| Reproducibility of Results | 3 | 2021 | 3054 | 0.080 |
Why?
| Catheterization | 2 | 2003 | 177 | 0.080 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2009 | 28 | 0.080 |
Why?
| Device Approval | 1 | 2009 | 21 | 0.080 |
Why?
| Adolescent | 7 | 2023 | 20355 | 0.080 |
Why?
| Workload | 1 | 2011 | 154 | 0.080 |
Why?
| Registries | 3 | 2025 | 2008 | 0.080 |
Why?
| Coated Materials, Biocompatible | 2 | 2023 | 56 | 0.080 |
Why?
| Safety | 1 | 2011 | 328 | 0.080 |
Why?
| Disability Evaluation | 1 | 2011 | 291 | 0.080 |
Why?
| Risk Management | 3 | 2007 | 92 | 0.080 |
Why?
| Axillary Vein | 1 | 2008 | 4 | 0.080 |
Why?
| Skin | 1 | 1993 | 737 | 0.080 |
Why?
| Global Health | 2 | 2021 | 333 | 0.080 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 421 | 0.070 |
Why?
| Saphenous Vein | 3 | 1998 | 32 | 0.070 |
Why?
| Athletic Injuries | 1 | 2014 | 517 | 0.070 |
Why?
| Radiography | 4 | 2015 | 863 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1969 | 0.070 |
Why?
| Colorado | 3 | 2016 | 4471 | 0.070 |
Why?
| Prevalence | 1 | 2014 | 2557 | 0.070 |
Why?
| Practice Guidelines as Topic | 2 | 2011 | 1529 | 0.070 |
Why?
| Antineoplastic Agents, Phytogenic | 2 | 2021 | 189 | 0.070 |
Why?
| Biomedical Research | 1 | 2013 | 656 | 0.070 |
Why?
| Family Practice | 2 | 2020 | 451 | 0.070 |
Why?
| Brachial Artery | 1 | 2008 | 205 | 0.070 |
Why?
| Iloprost | 1 | 2006 | 46 | 0.060 |
Why?
| Chemotherapy, Adjuvant | 1 | 2007 | 380 | 0.060 |
Why?
| Prospective Studies | 5 | 2021 | 7130 | 0.060 |
Why?
| Exercise Test | 3 | 2011 | 620 | 0.060 |
Why?
| Carotid Artery, Internal | 2 | 1996 | 41 | 0.060 |
Why?
| Regional Blood Flow | 2 | 1999 | 463 | 0.060 |
Why?
| United States Department of Veterans Affairs | 1 | 2009 | 637 | 0.060 |
Why?
| Sulfonic Acids | 1 | 2004 | 13 | 0.060 |
Why?
| Thrombophilia | 1 | 2025 | 68 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2019 | 2424 | 0.060 |
Why?
| Single-Blind Method | 2 | 2015 | 275 | 0.060 |
Why?
| Acetates | 1 | 2004 | 99 | 0.060 |
Why?
| Veins | 2 | 1995 | 60 | 0.060 |
Why?
| Specialty Boards | 1 | 2024 | 33 | 0.050 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 1008 | 0.050 |
Why?
| Thromboplastin | 1 | 2023 | 75 | 0.050 |
Why?
| Atherectomy | 1 | 2023 | 36 | 0.050 |
Why?
| Blood Pressure | 2 | 2021 | 1747 | 0.050 |
Why?
| Forecasting | 2 | 2001 | 364 | 0.050 |
Why?
| Physical Exertion | 1 | 2004 | 217 | 0.050 |
Why?
| Survival Analysis | 2 | 2004 | 1297 | 0.050 |
Why?
| Preoperative Care | 2 | 2002 | 345 | 0.050 |
Why?
| Sexism | 1 | 2023 | 54 | 0.050 |
Why?
| Diagnostic Techniques, Cardiovascular | 1 | 2002 | 12 | 0.050 |
Why?
| Societies, Medical | 2 | 2009 | 763 | 0.050 |
Why?
| Numbers Needed To Treat | 1 | 2021 | 8 | 0.050 |
Why?
| Morbidity | 1 | 2023 | 303 | 0.050 |
Why?
| Off-Label Use | 1 | 2022 | 51 | 0.050 |
Why?
| Mobility Limitation | 1 | 2022 | 63 | 0.050 |
Why?
| Psychomotor Performance | 1 | 2004 | 312 | 0.050 |
Why?
| Mass Screening | 1 | 2009 | 1130 | 0.050 |
Why?
| Frailty | 1 | 2024 | 148 | 0.050 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2001 | 6 | 0.050 |
Why?
| Adrenal Cortex Hormones | 1 | 2025 | 526 | 0.050 |
Why?
| Educational Measurement | 1 | 2024 | 259 | 0.050 |
Why?
| Vascular Neoplasms | 1 | 2001 | 17 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 828 | 0.050 |
Why?
| Angioplasty | 1 | 2001 | 47 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2004 | 680 | 0.050 |
Why?
| Cadaver | 1 | 2022 | 336 | 0.040 |
Why?
| Tetrazoles | 1 | 2001 | 35 | 0.040 |
Why?
| Aneurysm, False | 1 | 2001 | 46 | 0.040 |
Why?
| Heart Failure | 1 | 2014 | 2145 | 0.040 |
Why?
| Habits | 1 | 2020 | 43 | 0.040 |
Why?
| Equipment Failure | 1 | 2001 | 112 | 0.040 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 225 | 0.040 |
Why?
| Physician's Role | 1 | 2002 | 202 | 0.040 |
Why?
| Joint Dislocations | 1 | 2021 | 64 | 0.040 |
Why?
| Arterial Pressure | 1 | 2021 | 119 | 0.040 |
Why?
| Stents | 2 | 2022 | 520 | 0.040 |
Why?
| Radiography, Interventional | 1 | 2001 | 114 | 0.040 |
Why?
| Empathy | 1 | 2022 | 173 | 0.040 |
Why?
| Pregnancy Complications, Infectious | 1 | 2024 | 334 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2008 | 2783 | 0.040 |
Why?
| Prosthesis Design | 1 | 2022 | 322 | 0.040 |
Why?
| Artificial Limbs | 1 | 2003 | 171 | 0.040 |
Why?
| Diagnostic Imaging | 3 | 2007 | 328 | 0.040 |
Why?
| Internal Medicine | 1 | 2002 | 249 | 0.040 |
Why?
| Pulse | 1 | 1999 | 27 | 0.040 |
Why?
| Internationality | 1 | 2020 | 152 | 0.040 |
Why?
| Knee Injuries | 1 | 2021 | 98 | 0.040 |
Why?
| Toe Joint | 1 | 1999 | 11 | 0.040 |
Why?
| Proprotein Convertase 9 | 1 | 2020 | 66 | 0.040 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 207 | 0.040 |
Why?
| Pulsatile Flow | 1 | 1999 | 61 | 0.040 |
Why?
| Patient Education as Topic | 1 | 2024 | 745 | 0.040 |
Why?
| Debridement | 1 | 1999 | 87 | 0.040 |
Why?
| Metatarsal Bones | 1 | 1999 | 50 | 0.040 |
Why?
| Myocardial Revascularization | 1 | 2019 | 71 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2020 | 227 | 0.040 |
Why?
| Arteriovenous Fistula | 1 | 1998 | 37 | 0.040 |
Why?
| Catheters, Indwelling | 1 | 1998 | 79 | 0.040 |
Why?
| Postoperative Care | 1 | 2019 | 248 | 0.040 |
Why?
| Intraoperative Complications | 1 | 1998 | 133 | 0.040 |
Why?
| Knee Joint | 1 | 2021 | 366 | 0.040 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 67 | 0.040 |
Why?
| Antiviral Agents | 1 | 2023 | 709 | 0.030 |
Why?
| Carotid Arteries | 1 | 2019 | 207 | 0.030 |
Why?
| Coronary Disease | 1 | 2000 | 389 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2020 | 1213 | 0.030 |
Why?
| Diagnosis, Differential | 2 | 2014 | 1442 | 0.030 |
Why?
| Neck | 1 | 1997 | 92 | 0.030 |
Why?
| Age Factors | 1 | 2004 | 3145 | 0.030 |
Why?
| Administration, Oral | 1 | 2019 | 790 | 0.030 |
Why?
| Blood Loss, Surgical | 1 | 2016 | 91 | 0.030 |
Why?
| Health Promotion | 1 | 2022 | 734 | 0.030 |
Why?
| Risk | 1 | 2019 | 871 | 0.030 |
Why?
| Cardiology | 1 | 2019 | 282 | 0.030 |
Why?
| Postoperative Hemorrhage | 1 | 2016 | 85 | 0.030 |
Why?
| Fractures, Bone | 1 | 2021 | 421 | 0.030 |
Why?
| Aortic Rupture | 1 | 1995 | 26 | 0.030 |
Why?
| Pain Measurement | 2 | 2009 | 497 | 0.030 |
Why?
| Foot | 1 | 1996 | 125 | 0.030 |
Why?
| Aorta, Abdominal | 1 | 1995 | 45 | 0.030 |
Why?
| Groin | 1 | 1994 | 13 | 0.030 |
Why?
| Vaccination | 1 | 2023 | 1362 | 0.030 |
Why?
| Carotid Artery, External | 1 | 1993 | 3 | 0.030 |
Why?
| Orthopedic Equipment | 1 | 1993 | 5 | 0.030 |
Why?
| Glasgow Coma Scale | 1 | 2014 | 175 | 0.030 |
Why?
| Venous Insufficiency | 1 | 1993 | 11 | 0.030 |
Why?
| Operative Time | 1 | 2014 | 122 | 0.030 |
Why?
| Prosthesis Failure | 1 | 1994 | 120 | 0.030 |
Why?
| Cerebral Revascularization | 1 | 1993 | 18 | 0.030 |
Why?
| Tomography, X-Ray Computed | 2 | 2016 | 2539 | 0.030 |
Why?
| Carotid Artery, Common | 1 | 1993 | 37 | 0.030 |
Why?
| Cerebral Angiography | 1 | 1993 | 111 | 0.030 |
Why?
| Exercise | 1 | 2004 | 1931 | 0.030 |
Why?
| Ankle | 1 | 1993 | 79 | 0.030 |
Why?
| Longitudinal Studies | 2 | 1999 | 2670 | 0.030 |
Why?
| Arteritis | 1 | 1993 | 27 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 2016 | 292 | 0.030 |
Why?
| Pressure | 1 | 1993 | 238 | 0.030 |
Why?
| Housing | 1 | 1993 | 132 | 0.020 |
Why?
| Inflammation | 1 | 2023 | 2705 | 0.020 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1287 | 0.020 |
Why?
| Nursing Homes | 1 | 1993 | 154 | 0.020 |
Why?
| Cohort Studies | 1 | 2022 | 5410 | 0.020 |
Why?
| Lung | 1 | 2004 | 3928 | 0.020 |
Why?
| Pain | 2 | 2009 | 770 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2011 | 54 | 0.020 |
Why?
| Pneumonia | 1 | 2016 | 613 | 0.020 |
Why?
| Child | 2 | 2020 | 20963 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 5050 | 0.020 |
Why?
| Equipment Safety | 1 | 2009 | 41 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 1999 | 1719 | 0.020 |
Why?
| Ligation | 1 | 2008 | 87 | 0.020 |
Why?
| Length of Stay | 1 | 2014 | 1133 | 0.020 |
Why?
| Illinois | 1 | 2008 | 39 | 0.020 |
Why?
| Tissue and Organ Harvesting | 1 | 2008 | 75 | 0.020 |
Why?
| Equipment Design | 1 | 2009 | 527 | 0.020 |
Why?
| Smoking | 1 | 2015 | 1507 | 0.020 |
Why?
| Cardiovascular Agents | 1 | 2009 | 157 | 0.020 |
Why?
| Ulcer | 1 | 2007 | 28 | 0.020 |
Why?
| Constriction, Pathologic | 1 | 2008 | 230 | 0.020 |
Why?
| Magnetic Resonance Angiography | 1 | 2009 | 237 | 0.020 |
Why?
| Cerebral Arterial Diseases | 1 | 2007 | 44 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 731 | 0.020 |
Why?
| Drug Carriers | 1 | 2006 | 115 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2006 | 399 | 0.010 |
Why?
| Sterol O-Acyltransferase | 1 | 2004 | 4 | 0.010 |
Why?
| Acetamides | 1 | 2004 | 37 | 0.010 |
Why?
| Reference Values | 1 | 2006 | 792 | 0.010 |
Why?
| Hemodynamics | 1 | 2009 | 1097 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2006 | 763 | 0.010 |
Why?
| Cost-Benefit Analysis | 1 | 2007 | 617 | 0.010 |
Why?
| Hyperemia | 1 | 2004 | 48 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2004 | 414 | 0.010 |
Why?
| Lipids | 1 | 2006 | 614 | 0.010 |
Why?
| Ultrasonography | 1 | 2006 | 729 | 0.010 |
Why?
| Treatment Refusal | 1 | 2002 | 89 | 0.010 |
Why?
| Sulfonamides | 1 | 2004 | 494 | 0.010 |
Why?
| World Health Organization | 1 | 2000 | 109 | 0.010 |
Why?
| Costs and Cost Analysis | 1 | 2000 | 211 | 0.010 |
Why?
| Heart Function Tests | 1 | 2000 | 61 | 0.010 |
Why?
| Algorithms | 1 | 2007 | 1632 | 0.010 |
Why?
| Aneurysm, Ruptured | 1 | 1998 | 35 | 0.010 |
Why?
| Epoprostenol | 1 | 1999 | 135 | 0.010 |
Why?
| Models, Theoretical | 1 | 2000 | 551 | 0.010 |
Why?
| Gangrene | 1 | 1996 | 10 | 0.010 |
Why?
| Patient Satisfaction | 1 | 2000 | 642 | 0.010 |
Why?
| Embolization, Therapeutic | 1 | 1998 | 210 | 0.010 |
Why?
| Ultrasonography, Doppler, Color | 1 | 1995 | 37 | 0.010 |
Why?
| Health Status | 1 | 2000 | 751 | 0.010 |
Why?
| Behcet Syndrome | 1 | 1993 | 18 | 0.010 |
Why?
| Takayasu Arteritis | 1 | 1993 | 15 | 0.010 |
Why?
| Infant, Newborn | 1 | 1999 | 5752 | 0.000 |
Why?
|
|
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|